4.7 Article

Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Critical Care Medicine

Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis

George Z. Retsch-Bogart et al.

Article Critical Care Medicine

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

Karen S. McCoy et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Multidisciplinary Sciences

Dynamics of Pseudomonas aeruginosa genome evolution

Kalai Mathee et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Infectious Diseases

Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis

Christine Etherington et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)

Review Critical Care Medicine

Cystic fibrosis pulmonary guidelines - Chronic medications for maintenance of lung health

Patrick A. Flume et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Medicine, General & Internal

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis

ZH Li et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Review Critical Care Medicine

Pathophysiology and management of pulmonary infections in cystic fibrosis

RL Gibson et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)

Article Critical Care Medicine

Factors influencing outcomes in cystic fibrosis - A center-based analysis

C Johnson et al.

Article Microbiology

Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa

N Masuda et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)